Insulet Corp. (PODD)
139.39
+2.16
(+1.57%)
USD |
NASDAQ |
Nov 20, 10:47
Insulet Free Cash Flow : 232.60M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | 232.60M |
| June 30, 2026 | 265.70M |
| March 31, 2026 | 387.80M |
| December 31, 2025 | 349.90M |
| September 30, 2025 | 407.70M |
| June 30, 2025 | 382.50M |
| March 31, 2025 | 280.80M |
| December 31, 2024 | 296.30M |
| September 30, 2024 | 217.90M |
| June 30, 2024 | 182.10M |
| March 31, 2024 | 136.40M |
| December 31, 2023 | 36.20M |
| September 30, 2023 | -14.80M |
| June 30, 2023 | -25.60M |
| March 31, 2023 | -45.30M |
| December 31, 2022 | -38.30M |
| September 30, 2022 | -63.00M |
| June 30, 2022 | -140.80M |
| March 31, 2022 | -151.90M |
| December 31, 2021 | -190.80M |
| September 30, 2021 | -199.10M |
| June 30, 2021 | -126.50M |
| March 31, 2021 | -120.00M |
| December 31, 2020 | -82.50M |
| September 30, 2020 | -14.79M |
| Date | Value |
|---|---|
| June 30, 2020 | -25.26M |
| March 31, 2020 | -59.65M |
| December 31, 2019 | -67.54M |
| September 30, 2019 | -68.90M |
| June 30, 2019 | -97.80M |
| March 31, 2019 | -125.70M |
| December 31, 2018 | -126.46M |
| September 30, 2018 | -129.71M |
| June 30, 2018 | -93.41M |
| March 31, 2018 | -28.14M |
| December 31, 2017 | -36.02M |
| September 30, 2017 | -11.25M |
| June 30, 2017 | -36.40M |
| March 31, 2017 | -40.04M |
| December 31, 2016 | -6.204M |
| September 30, 2016 | -45.44M |
| June 30, 2016 | -28.60M |
| March 31, 2016 | -29.00M |
| December 31, 2015 | -23.16M |
| September 30, 2015 | 0.891M |
| June 30, 2015 | -3.616M |
| March 31, 2015 | -7.226M |
| December 31, 2014 | -2.566M |
| September 30, 2014 | -10.85M |
| June 30, 2014 | -10.69M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp. | 3.331B |
| Abbott Laboratories | 6.757B |
| TransMedics Group, Inc. | 44.70M |
| The Cooper Cos., Inc. | 678.00M |
| Stryker Corp. | 4.573B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 123.40M |
| Cash from Investing (Quarterly) | -66.90M |
| Cash from Financing (Quarterly) | -6.00M |
| Free Cash Flow Per Share (Quarterly) | 0.885 |
| Free Cash Flow to Equity (Quarterly) | 47.80M |
| Free Cash Flow to Firm (Quarterly) | 74.40M |
| Free Cash Flow Yield | 2.41% |